Health insurer Cigna will stop covering GLP-1 weight-loss drugs including Novo Nordisk’s Wegovy and Eli Lilly’s Zepbound in its employee health plan effective July 1, according to materials viewed by Reuters on Tuesday.[#item_full_content]
Tentato femminicidio a Vicenza: accoltella la compagna e le frattura il cranio
Novembre 7, 2026
Read More [#item_full_content]
